Maple Rock Capital Partners Inc. Raises Stake in Humana Inc. $HUM

Maple Rock Capital Partners Inc. lifted its stake in Humana Inc. (NYSE:HUM) by 82.2% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 628,251 shares of the insurance provider’s stock after buying an additional 283,451 shares during the quarter. Humana comprises 5.0% of Maple Rock Capital Partners Inc.’s portfolio, making the stock its 4th biggest holding. Maple Rock Capital Partners Inc. owned 0.52% of Humana worth $249,554,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently bought and sold shares of the company. Revolve Wealth Partners LLC bought a new stake in Humana in the fourth quarter worth $202,000. Woodline Partners LP increased its position in Humana by 460.0% during the first quarter. Woodline Partners LP now owns 10,192 shares of the insurance provider’s stock valued at $2,697,000 after acquiring an additional 8,372 shares during the last quarter. Sivia Capital Partners LLC raised its position in Humana by 53.7% in the 2nd quarter. Sivia Capital Partners LLC now owns 1,293 shares of the insurance provider’s stock worth $316,000 after purchasing an additional 452 shares during the period. Cresset Asset Management LLC lifted its stake in shares of Humana by 10.3% during the 2nd quarter. Cresset Asset Management LLC now owns 2,369 shares of the insurance provider’s stock worth $581,000 after acquiring an additional 222 shares during the last quarter. Finally, WINTON GROUP Ltd lifted its position in shares of Humana by 58.5% during the second quarter. WINTON GROUP Ltd now owns 2,381 shares of the insurance provider’s stock worth $582,000 after purchasing an additional 879 shares during the last quarter. Institutional investors own 92.38% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on HUM shares. Lake Street Capital initiated coverage on Humana in a report on Thursday, July 30th. They issued a “buy” rating for the company. TD Cowen lifted their price target on shares of Humana from $350.00 to $370.00 and gave the stock a “hold” rating in a report on Friday, July 31st. Cantor Fitzgerald boosted their price target on Humana from $264.00 to $300.00 and gave the stock a “neutral” rating in a research note on Tuesday, July 7th. Deutsche Bank Aktiengesellschaft assumed coverage on Humana in a research report on Thursday, July 30th. They issued a “hold” rating on the stock. Finally, Morgan Stanley raised Humana from an “underweight” rating to an “equal weight” rating and increased their price objective for the company from $249.00 to $370.00 in a report on Tuesday, August 4th. Fourteen analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, Humana presently has a consensus rating of “Hold” and a consensus target price of $403.91.

Humana Stock Down 0.3%

Shares of HUM opened at $384.25 on Tuesday. The stock has a 50 day moving average price of $386.07 and a 200 day moving average price of $290.60. Humana Inc. has a one year low of $163.11 and a one year high of $428.88. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.74 and a current ratio of 1.74. The stock has a market capitalization of $46.14 billion, a price-to-earnings ratio of 36.35, a PEG ratio of 2.20 and a beta of 0.72.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share for the quarter, beating analysts’ consensus estimates of $7.27 by $0.34. Humana had a return on equity of 11.20% and a net margin of 0.88%.The company had revenue of $40.89 billion for the quarter, compared to analyst estimates of $40.58 billion. During the same quarter last year, the firm posted $6.27 EPS. The firm’s revenue for the quarter was up 26.2% on a year-over-year basis. Equities research analysts forecast that Humana Inc. will post 9.12 earnings per share for the current fiscal year.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.